参考文献/References:
1 Owen DG,McNamee JP,Raaphorst GP,et al.Potentiation of cell killing by low-dose-rate radiation by camptothecin is related to an increase in the level of DNA double-strand breaks.Radiat Res,2002,157(2):149-157.
2 郑秀龙,金一尊,沈瑜.肿瘤治疗增敏药.修订本,上海:上海科学技术文献出版社,2002.152-156.
3 Lahusen T,De Siervi A,Kunick C,et al.Alsterpaullone,a novel cyclin-dependent kinase inhibitor,induces apoptosis by activation of caspase-9 due to perturbation in mitochondrial membrane potential.Mol Carcinog,2003,36(4):183-194.
4 Iliakis G,Wang H,Perrauh AR,et al.Mechanisms of DNA double strand break repair and chromosome aberration formation.Cytogenet Genome Res,2004,104(1-4):14-20.
5 Wouters BG,Weppler SA,Koritzinsky M,et al.Hypoxia as a target for combined modality treatments.Eur J Cancer,2002,38(2):240-257.
6 Pradier O,Rave-Frank M,Schmidberger H,et al.Effects of paclitaxel in combination with radiation on human head and neck cancer cells (ZMK-1),cervical squamous cell carcinoma cellscarcinoma (CaSki),and breast adenocarcinoma cells(MCF-7).J Cancer Res Clin Oncol,1999,125(1):20-27.
7 Kotandeniya D,Ganley B,Gates KS,et al.Oxidatine DNA base damage by the antitumor agent 3-amino-1,2,4-benzotriazine 1,4-dioxide.Biol Med Chem Lett,2002,12(17):2325-2329.
8 Maraveyas A,Sgouros J,Upadhyay S,et al.Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma:a phase I study.Br J Cancer,2005,92(5):815-819.
9 姚莉.辐射损伤与细胞周期.国外医学·放射医学核医学分册,2004,28(1):33-36.
10 Sarkaria JN,Busby EC,Tibbetts RS,et al.Inhibition of ATM and ATR kinase activities by the radiosensitizing agent,caffeine.Cancer Res,1999,59(17):4375-4382.
11 Tenzer A,Pruschy M.Potentiation of DNA-damage-induced cytotoxicity by G2 checkpoint abrogators.Cur Med Chem Anticancer Agents,2003,3(1):35-46.
12 Moon C,Oh Y,Roth JA.Current status of gene therapy for lung cancer and head and neck cancer.Clin Cancer Res,2003,9(14):5055-5067.
13 王小兵,赵桂森.抗肿瘤放射增敏剂的研究进展.中南药学,2005,3(5):293-295.
14 Kasid U,Dritschilo A.RAF antisense oligonuclectide as a tumor radiosensitizer.Oncogene,2003,22(37):5876-5884.
15 Guha C,Guha U,Tribius S,et al.Antisense ATM gene therapy:a strategy to increase the radiosensitivity of human tumors.Gene Ther,2000,7(10):852-858.
16 Herbst RS.Review of epidermal growth factor receptor biology.Int J Radiat Oncol Biol Phys,2004,59(2 Supp1):21-26.
17 Lammering G,Hewit TH,Hawkins WT,et al.Epidermal growth factor receptor as a genetic therapy target for carcinoma cell radiosensitization.J Natl Cancer Inst,2001,93(12):921-929.
18 Huang SM,Harari PM.Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas:inhibition of damage repair,cell cycle kinetics,and tumorangiogenesia Clin CancerRes,2000,6(6):2166-2174.
相似文献/References:
[1]霍小东,王慧星,阎卫亮,等.血管内皮抑制素对125I近距离照射裸鼠肺癌移植瘤的增敏效应研究[J].国际放射医学核医学杂志,2016,40(5):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
Huo Xiaodong,Wang Huixing,Yan Weiliang,et al.Sensitization effect of endostatin for 125I brachytherapy on transplanted tumor in nude mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
[2]刘晓秋,周则卫,沈秀,等.放射增敏剂尼可胺对Wistar大鼠致畸作用的研究[J].国际放射医学核医学杂志,2013,37(2):81.[doi:10.3760/cma.j.issn.1673-4114.2013.02.005]
LIU Xiao-qiu,ZHOU Ze-wei,SHEN Xiu,et al.Study on teratogenicity of Nikean in Wistar rats[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):81.[doi:10.3760/cma.j.issn.1673-4114.2013.02.005]
[3]黄少祥,樊体强.塞来昔布对非小细胞肺癌移植瘤的辐射增敏实验研究[J].国际放射医学核医学杂志,2013,37(3):150.[doi:10.3760/cma.j.issn.1673-4114.2013.03.006]
HUANG Shao-xiang,FAN Ti-qiang.Radiosensitization on non-small cell lung cancer induced by celecoxib[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):150.[doi:10.3760/cma.j.issn.1673-4114.2013.03.006]
[4]李卫红,王浩,周晓靓,等.肿瘤放射治疗增敏剂研究新进展[J].国际放射医学核医学杂志,2013,37(4):233.[doi:10.3760/cma.j.issn.1673-4114.2013.04.011]
LI Wei-hong,WANG Hao,ZHOU Xiao-liang,et al.Radiosensitizers development and the pathways[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):233.[doi:10.3760/cma.j.issn.1673-4114.2013.04.011]
[5]刘晓秋,沈秀,王芹,等.尼可胺在大鼠体内的药代动力学研究[J].国际放射医学核医学杂志,2013,37(5):265.[doi:10.3760/cma.j.issn.1673-4114.2013.05.003]
LIU Xiao-qiu,SHEN Xiu,WANG Qin,et al.Study on pharmacokinetics of NiKeAn in rat[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):265.[doi:10.3760/cma.j.issn.1673-4114.2013.05.003]
[6]司宏伟,徐慧琴,岳峤,等.肿瘤组织乏氧与葡萄糖代谢[J].国际放射医学核医学杂志,2009,33(4):200.[doi:10.3760/cma.j.issn.1673-4114.2009.04.003]
SI Hong-wei,XU Hui-qin,YUE Qiao,et al.Hypoxia and glycometabolism in cancer tissue[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(5):200.[doi:10.3760/cma.j.issn.1673-4114.2009.04.003]
[7]林伟,邬恒夫,武兆忠,等.99mTc-HL91显像在缺血陛脑血管病中脑乏氧组织的应用研究[J].国际放射医学核医学杂志,2008,32(3):165.
LIN Wei,WU Heng-fu,WU Zhao-zhong,et al.Preliminary study on detection of brain hypoxic tissue in the patients with ischemic cerebrovascular of brain using 99mTc-HLgl imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(5):165.
[8]杜雪梅,张延军.核素乏氧显像在肿瘤放射治疗中的应用[J].国际放射医学核医学杂志,2008,32(2):96.
DU Xue-mei,ZHANG Yan-jun.Clinical application of nuclear hypoxia imaging on oncology radiation therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(5):96.
[9]郭阳.红细胞生成素及其受体与肿瘤组织乏氧的关系及对治疗的影响[J].国际放射医学核医学杂志,2007,31(5):306.
GUO Yang.Erythropoietin and erythropoietin receptor: relationship to tumor hypoxia and treatment[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(5):306.
[10]薛咏,刘生,张弘,等.鼻咽癌乏氧程度与放疗中期肿瘤退缩关系的初步研究[J].国际放射医学核医学杂志,2007,31(4):232.
XUE Yong,LIU Sheng,ZHANG Hong,et al.The relationship between tumor regression degree and its hypoxia degree in patients with nasopharyngeal carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(5):232.